Medicare Enrolled

Dr. Steven Lovitt, M.D.

Neurology · Allentown, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
240 CETRONIA RD # 210A, Allentown, PA 18104
4845265210
In practice since 2005 (20 years)
NPI: 1114912748 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lovitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lovitt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lovitt

Dr. Steven Lovitt is a neurology specialist in Allentown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lovitt performed 11,701 Medicare services across 603 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lovitt received a total of $216,494 from 79 pharmaceutical and/or device companies across 1656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lovitt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 3% volume in PA $216,494 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,701
Medicare services
Top 3% in PA for neurology
603
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~585 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
10,670 $36 $116
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
239 $15 $58
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
191 $80 $280
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
121 $96 $326
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
116 $47 $213
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
114 $121 $465
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $60 $220
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
60 $180 $800
New patient office visit, complex (60-74 min) 47 $160 $592
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
30 $189 $907
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
29 $100 $340
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
11 $129 $372
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
94.2% high complexity
0.0% medium
5.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$216,494
Total received (2018-2024)
Avg $30,928/year across 7 years
Top 5% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,656
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$196,003 (90.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,492 (9.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$53
2023
$5,418
2022
$22,618
2021
$20,037
2020
$15,106
2019
$82,724
2018
$70,538

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$31
Abbott Laboratories
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$195,088
Sunovion Pharmaceuticals Inc.
$2,286
GENZYME CORPORATION
$1,544
Novartis Pharmaceuticals Corporation
$1,483
Biogen, Inc.
$1,158
Teva Pharmaceuticals USA, Inc.
$1,145
Supernus Pharmaceuticals, Inc.
$1,046
Grifols USA, LLC
$1,041
Amgen Inc.
$962
EMD Serono, Inc.
$877
UCB, Inc.
$837
SK Life Science, Inc.
$759
CSL Behring
$720
ARGENX US, INC.
$597
Horizon Therapeutics plc
$510
Amneal Pharmaceuticals LLC
$438
Genentech USA, Inc.
$401
ACADIA Pharmaceuticals Inc
$332
Neurocrine Biosciences, Inc.
$329
Acorda Therapeutics, Inc
$320
ABBVIE INC.
$285
Abbott Laboratories
$243
Bausch Health US, LLC
$225
PFIZER INC.
$202
Lilly USA, LLC
$198
Celgene Corporation
$192
AbbVie Inc.
$181
Nevro Corp.
$171
EISAI INC.
$161
Biohaven Pharmaceuticals, Inc.
$159
Eisai Inc.
$156
Biohaven Pharmaceutical Holding Company Ltd.
$151
Kyowa Kirin, Inc.
$132
Allergan, Inc.
$121
Upsher-Smith Laboratories LLC
$111
Impax Laboratories, Inc.
$108
Allergan Inc.
$105
Lundbeck LLC
$105
Assertio Therapeutics, Inc.
$97
Takeda Pharmaceuticals U.S.A., Inc.
$95
Adamas Pharmaceuticals, Inc.
$94
Merz North America, Inc.
$82
CATALYST PHARMACEUTICALS, INC.
$80
Avion Pharmaceuticals
$76
Mitsubishi Tanabe Pharma America, Inc.
$76
Mallinckrodt Hospital Products Inc.
$74
IMPEL PHARMACEUTICALS INC.
$74
Sumitomo Pharma America, Inc.
$60
Endo Pharmaceuticals Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$59
GE HEALTHCARE
$49
Egalet US Inc
$48
Vertical Pharmaceuticals, LLC
$44
Mallinckrodt LLC
$40
Octapharma USA, Inc.
$39
Alnylam Pharmaceuticals Inc.
$36
ARBOR PHARMACEUTICALS, INC.
$35
E.R. Squibb & Sons, L.L.C.
$34
ASSERTIO THERAPEUTICS, Inc.
$31
Promius Pharma LLC
$29
Corium, LLC
$25
LivaNova USA, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$21
JAZZ PHARMACEUTICALS INC.
$20
Apria Healthcare LLC
$19
Greenwich Biosciences, Inc.
$17
GRT US Holding, Inc.
$17
Mylan Specialty L.P.
$17
Mylan Pharmaceuticals Inc.
$17
Averitas Pharma Inc.
$15
Currax Pharmaceuticals LLC
$15
Strongbridge US INC.
$14
Janssen Pharmaceuticals, Inc
$14
BANNER LIFE SCIENCES, LLC
$13
GE HealthCare
$13
Shire North American Group Inc
$13
UPSHER-SMITH LABORATORIES LLC
$12
Retrophin, Inc.
$10
Piramal Imaging Limited
$8
Top 3 companies account for 91.9% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COPAXONE · Cambia · DIVIGEL · DUOPA · Dhivy · EMGALITY · Edarbi · Enspryng · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gralise · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Medela · NASCOBAL · NEURACEQ · NOURIANZ · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ongentys · Ozanimod · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RYTARY · Radicava · Rebif · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Senza Spinal Cord Stimulation System · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VNS - Sentiva · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · XCOPRI · XEOMIN · ZEPOSIA · ZOMIG · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurology in PA.

Looking for a neurology specialist in Allentown?
Compare neurologists in the Allentown area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
106
Per 100K population
28.2
County median income
$77,493
Nearest hospital
LEHIGH VALLEY HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lovitt is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with speaking/promotional industry engagement in the top 5% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lovitt experienced with immune globulin infusion (gammagard)?
Based on Medicare claims data, Dr. Lovitt performed 10,670 immune globulin infusion (gammagard) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lovitt receive payments from pharmaceutical companies?
Yes. Dr. Lovitt received a total of $216,494 from 79 companies across 1,656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lovitt's costs compare to other neurologists in Allentown?
Dr. Lovitt's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lovitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →